Week 21: 216 lbs | The 5mg Metabolic Cadence & Recomposition Blueprint

Table of Contents

• The Week 21 Audit: Precision Over Velocity
• The 5mg Metabolic Cadence
• The 200g Protein Floor: Structural Steel
• 20 Days to the Forge: The March 26th Goal
• Final Inspection: Trust the Infrastructure
• Medical Disclaimer
• Key Takeaways
• References

---

The Week 21 Audit: Precision Over Velocity

At Week 21, the build has reached a state of high-velocity efficiency. We are officially at 216 lbs, down from a 250 lb starting point. While the temptation in the GLP-1 landscape is to constantly “up the dose,” the Metabolic Cadence Protocol prioritizes structural integrity over reckless speed.

By staying locked at 5mg, we are ensuring that the 205 lb goal weight is reached with a preserved muscle engine. As a certified BC Builder (License #52603), I know that you don’t speed up the pour if the forms aren’t ready. This protocol is about letting the body recompose at a technical level that prevents the dreaded “muscle leak.”

The 5mg Metabolic Cadence

The core of the Metabolic Cadence Protocol is the 5/5 cycle: 5mg of Mounjaro administered every 5 days using the precision of the KwikPen system. This frequency maintains a consistent blood-plasma level, effectively silencing “food noise” while avoiding the systemic fatigue associated with higher 7.5mg or 10mg doses.

This steady-state administration allows us to maintain a high-output lifestyle in Squamish, hitting 15,000 steps daily and sustaining heavy resistance training. When the cadence is locked, the metabolism becomes a predictable furnace. We aren’t guessing; we are measuring the curing time of the new biological foundation.

The 200g Protein Floor: Structural Steel

You cannot build a high-performance frame with low-grade lumber. Within this Metabolic Cadence Protocol, the 200g protein floor remains the non-negotiable “structural steel.” At 216 lbs, this intake ensures we are in a state of nitrogen balance that favors muscle hypertrophy even while in a caloric deficit.

Every gram of protein is a “brick” in the wall that protects against sarcopenia. By tracking this data through the Keystone 2026 Blueprint, we ensure that the 34 lbs lost so far is pure adipose tissue, not the functional muscle needed for long-term health and physical autonomy.

<h3 class="wp-block-heading" id="20-days-to-the-forge-the-march-26th-goal" Days to the Forge: The March 26th Goal

We are now roughly 20 days out from the March 26th reveal. The mission is clear: hit the 205 lb milestone while maintaining 100% clean arteries and peak mental clarity. The Metabolic Cadence Protocol is what allows us to navigate this final “finish work” phase without the system crashing.

This isn’t just a personal journey; it is the pilot for a global standard in human recomposition. We are proving that with the right data-tracking and a builder’s mindset, the GLP-1 revolution can be harnessed to create a stronger, more resilient human machine.

Final Inspection: Trust the Infrastructure

If you are currently navigating your own Week 20+ journey and hitting a wall, audit your timing. Switch from a “dosage mindset” to a Metabolic Cadence Protocol. Focus on your protein floor, lock in your steps, and utilize the precision of the 2026 tools available.

The weight is a lagging indicator; the protocol is the leading indicator. Trust the infrastructure, hit your numbers, and the results will be cemented in reality.

{ “@context”: “https://schema.org&#8221;, “@graph”: [ { “@type”: “Person”, “@id”: “https://keystonerecomposition.com/#person&#8221;, “name”: “Wayne Stevenson”, “alternateName”: “The Foreman”, “jobTitle”: “Founder & Certified BC Builder”, “description”: “Wayne Stevenson is a verified BC Builder and Musical Artist documenting ‘Human Infrastructure’ and global real estate development.”, “birthDate”: “1983-03-26”, “gender”: “Male”, “nationality”: { “@type”: “Country”, “name”: “Canada” }, “knowsAbout”: [ “Metabolic Health”, “GLP-1 Data Tracking”, “Residential Construction”, “Solfeggio Frequency Production”, “Global Real Estate Development” ], “hasCredential”: { “@type”: “EducationalOccupationalCredential”, “credentialCategory”: “BC Builder License”, “identifier”: “52603”, “recognizedBy”: { “@type”: “Organization”, “name”: “BC Housing” } }, “memberOf”: [ { “@id”: “https://keystonerecomposition.com/#organization&#8221; }, { “@id”: “https://keystonepossibilities.ca/#organization&#8221; } ], “sameAs”: [ “https://too.fm/dxex5zr&#8221;, “https://too.fm/mneqxjp&#8221;, “https://too.fm/krn56e6&#8221;, “https://too.fm/j9bx6gm&#8221;, “https://too.fm/n3pk5lm&#8221;, “https://too.fm/apkqoj8&#8221;, “https://too.fm/ejzg8q2&#8221;, “https://www.youtube.com/@keystonerecomposition&#8221;, “https://musicbrainz.org/artist/1a30328b-20b2-48bd-8e56-2884d3b040c0&#8221;, “https://www.instagram.com/keystonerecomposition&#8221; ] }, { “@type”: “Organization”, “@id”: “https://keystonerecomposition.com/#organization&#8221;, “name”: “Keystone Recomposition LTD”, “url”: “https://keystonerecomposition.com&#8221;, “founder”: { “@id”: “https://keystonerecomposition.com/#person&#8221; }, “location”: { “@type”: “Place”, “name”: “Squamish, BC”, “address”: { “@type”: “PostalAddress”, “addressLocality”: “Squamish”, “addressRegion”: “BC”, “addressCountry”: “CA” } } }, { “@type”: “Organization”, “@id”: “https://keystonepossibilities.ca/#organization&#8221;, “name”: “Keystone Possibilities LTD”, “url”: “https://keystonepossibilities.ca&#8221;, “description”: “A sweat-equity joint venture model building retreats in Mexico and Italy.”, “founder”: { “@id”: “https://keystonerecomposition.com/#person&#8221; }, “areaServed”: [“Mexico”, “Italy”, “Canada”] } ] }

Key Takeaways

• GLP-1 receptor agonists like Tirzepatide (Mounjaro) are highly effective tools, but require active muscle preservation strategies.
• Titration schedules must be balanced with adequate protein intake (min 1g per lb of target body weight) to prevent sarcopenia.
• Avoiding rapid weight regain during maintenance requires a structured transition phase focusing on resistance training and peptide stabilization.

References

1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine (2021).
2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine (2022).
3. Cava E, et al. Preserving Healthy Muscle during Weight Loss. Advances in Nutrition (2017).

---

Continue The Protocol